Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00585325 · ClinicalTrials.gov registry record · NA

Instilled Lidocaine vs Placebo for Pain Management During Vacuum Assisted Closure (VAC) Dressing Changes

A NA study, sponsored by University of Wisconsin, Madison.

Completed
Registry status
NA
Development phase
15
Enrollment target

NCT00585325 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 15 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00585325, a NA study, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target

Study Summary

Patients will be randomized prospectively to one of two groups. One group will receive 5 mg/kg of 1% lidocaine, and the other will receive .9 normal saline, instilled into their VAC sponge ½ hour prior to VAC dressing change. All patients will complete a pain assessment tool prior to receiving the instilled lidocaine/placebo, immediately after the procedure and 1 hour after the procedure. Pain scores will then be compared between the lidocaine and placebo groups. Risks: Lidocaine toxicity is a potential risk, but 5 mg/kg of 1 % Lidocaine is below toxicity thresholds in an adult.

Interventions

  • DRUG Instilled 1% Lidocaine
  • OTHER Placebo (0.9% Normal Saline)

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2004-10
Est. Completion 2008-11
Phase NA

Sponsor

University of Wisconsin, Madison

1,039 total trials

What the Registry Record Tells You About NCT00585325

The ClinicalTrials.gov registry entry for NCT00585325 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Instilled 1% Lidocaine is the first listed.

NCT00585325 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00585325 about?

NCT00585325 is a clinical study titled "Instilled Lidocaine vs Placebo for Pain Management During Vacuum Assisted Closure (VAC) Dressing Changes". Patients will be randomized prospectively to one of two groups. One group will receive 5 mg/kg of 1% lidocaine, and the other will receive .9 normal saline, instilled into their VAC sponge ½ hour prior to VAC dressing change. All patients will complete a pain assessment tool prior to receiving the i...

What is the current status of trial NCT00585325?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2004-10. Estimated completion is 2008-11.

What interventions are being tested in trial NCT00585325?

The interventions under investigation include: Instilled 1% Lidocaine (DRUG), Placebo (0.9% Normal Saline) (OTHER).

Who is sponsoring clinical trial NCT00585325?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.